ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625497 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625497; 2) Community: the network communities that were significantly associated with the response to NSC 625497; 3) Molecule: the relationships between components within communities and NSC 625497; 4) MDR: the compounds that were significantly associated with the NSC 625497.

NSC Compound Enrichment Correlation
NSC 303861 L-Cysteine analog 0.0235234559682125 0.5808138
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0235234559682125 0.26234925
NSC 371777 Null 0.0235234559682125 0.15139689
NSC 39215 Null 0.0235234559682125 0.47103718
NSC 603071 Aminocamptothecin 0.0235234559682125 0.14372108
NSC 604976 Verrucarin A, 7'-deoxo-2'-deoxy-2',3'-epoxy-8',9',10',11'- tetrahydro-4',8-dihydroxy-7'-(1-hydroxyethyl)- 0.0235234559682125 0.57813234
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0235234559682125 0.59737177
NSC 63878 Cytarabine Hydrochloride AZ 0.0235234559682128 0.30153964
NSC 645665 Null 0.0235234559682128 0.3391986
NSC 651605 Null 0.0235234559682128 0.23259085
Total:80  Current:41    [First] [Prev] [Next] [Last]